A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/0812/31/10

Funding

  • Kendle International: $10,008.00